BK

Basineni Krishnavardhan Chowdary

Active Director Director DIN 10877932
DIN 10877932 First appointment Dec 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Basineni Krishnavardhan Chowdary

Data last updated:

Basineni Krishnavardhan Chowdary is a Director at Sisira Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10877932
Primary Designation Director
Industry Paper
First Appointment 19 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Dec 20242024Active

Board colleagues of Basineni Krishnavardhan Chowdary

NameDINCompanyDesignation
Venkatesh Kommanaboyina10877933Sisira Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sisira Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Basineni Krishnavardhan Chowdary

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Basineni Krishnavardhan Chowdary

Basineni Krishnavardhan Chowdary currently holds 1 directorship: Sisira Pharmaceuticals Private Limited (Director, since 19 Dec 2024).

Basineni Krishnavardhan Chowdary was first appointed on 19 Dec 2024 as Director at Sisira Pharmaceuticals Private Limited.

The current boards of Basineni Krishnavardhan Chowdary's companies include Venkatesh Kommanaboyina (Sisira Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available